Close

Analyst Ratings for POINT Biopharma Global Inc. (PNT)

PNT Rating Summary

PNT Price Target Summary

* Over Last 12-Mos
  |   Expand Research on PNT
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $13.17 (+5.3%) * Over Last 12-Mos
Rating Score: 4.2 / 10   Percentile Rank: 42%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/21/2023 Brookline Capital Markets Kemp Dolliver Downgrade Hold
(Buy)
12.50
(27.00)
12.45
(12.50)
0.4% Details
10/24/2023 Piper Sandler Edward Tenthoff Downgrade Neutral
(Overweight)
12.50
(N/A)
12.95
(12.50)
-3.47% Details
Like PNT Ratings? Also take a look at LLY, LNTH, RYZB, BMY

PNT Ratings News